2- OR 4-Hydroxy-3,5-dihalo-benzylamines and salts thereof
    1.
    发明授权
    2- OR 4-Hydroxy-3,5-dihalo-benzylamines and salts thereof 失效
    2-或4-羟基-3,5-二卤代苄胺及其盐

    公开(公告)号:US4113777A

    公开(公告)日:1978-09-12

    申请号:US812325

    申请日:1977-07-01

    IPC分类号: A61K31/135 C07C87/28

    摘要: Compounds of the formula ##STR1## wherein X and R.sub.1 are each chlorine or bromine;R.sub.2 is isopropyl; tert.butyl; tert.pentyl; mono-, di- or tri-hydroxy-substituted branched alkyl of 3 to 5 carbon atoms; cyclohexyl; or hydroxycyclohexyl; andR.sub.3 is alkyl of 1 to 4 carbon atoms or, when R.sub.2 is other than cyclohexyl, also hydrogen;And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as secretolytics, antitussives, anti-ulcerogenics and stimulants for the production of the surfactant or antiatelectasis factor of the alveoli.

    摘要翻译: 其中X和R 1各自为氯或溴的式“IMAGE”的化合物; R2是异丙基; 叔丁基 叔戊基 3至5个碳原子的单,二或三羟基取代的支链烷基; 环己基 或羟基环己基; 并且R 3是1至4个碳原子的烷基,或者当R 2不是环己基时,也是氢; 和非毒性,药理学上可接受的酸添加量; 化合物作为其生物利用作为秘密,抗生素,抗生素和抗生素用于生产ALVEOLI的表面活性剂或抗原决定因子。

    Halo-substituted hydroxybenzyl-amines as secretolytic agents
    2.
    发明授权
    Halo-substituted hydroxybenzyl-amines as secretolytic agents 失效
    卤代取代的羟基苄基胺作为分泌溶剂

    公开(公告)号:US4073942A

    公开(公告)日:1978-02-14

    申请号:US635220

    申请日:1975-11-25

    IPC分类号: A61K31/135 C07C87/29

    摘要: Compounds of the formula ##STR1## wherein X is chlorine or bromine;R.sub.1 is hydrogen, chlorine or bromine;R.sub.2 is isopropyl; tert.butyl; tert.pentyl; mono-, di- or tri-hydroxy-substituted branched alkyl of 3 to 5 carbon atoms; cyclohexyl; or hydroxycyclohexyl; andR.sub.3 is alkyl of 1 to 4 carbon atoms or, when R.sub.2 is other than cyclohexyl, also hydrogen;And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as secretolytics, antitussives, anti-ulcerogenics and stimulants for the production of the surfactant or anti-atelectasis factor of the alveoli.

    摘要翻译: 其中X是氯或溴的式“IMAGE”的化合物; R1是氢,氯或溴; R2是异丙基; 叔丁基 叔戊基 3至5个碳原子的单,二或三羟基取代的支链烷基; 环己基 或羟基环己基; 并且R 3是1至4个碳原子的烷基,或者当R 2不是环己基时,也是氢; 和非毒性,药理学上可接受的酸添加量; 该化合物作为其生物利用作为秘密,抗生素,抗生素和抗生素用于生产ALVEOLI的表面活性剂或抗原决定因子。

    Pharmaceutical compositions containing an aminobenzyl-amine and method
of use
    3.
    发明授权
    Pharmaceutical compositions containing an aminobenzyl-amine and method of use 失效
    含氨基苄基胺的药物组合物及其使用方法

    公开(公告)号:US4006246A

    公开(公告)日:1977-02-01

    申请号:US649481

    申请日:1976-01-15

    CPC分类号: A61K31/19 A61K31/135

    摘要: Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkanoyl, benzoyl or halobenzoyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is carboxyl or lower carbalkoxy, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy-(alkyl of 1 to 5 carbon atoms), alkenyl or 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy-(cycloalkyl of 5 to 7 carbon atoms) or benzyl,Or a non-toxic, pharmacologically acceptable acid addition salt thereof; and a method of using the same as anti-ulcerogenics, secretolytics, antitussives, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.

    摘要翻译: 含有下式化合物作为活性成分的药物剂量单位组合物,其中R 1是氢,低级烷酰基,苯甲酰基或卤代苯甲酰基,R 2是氢,氯或溴,R 3是羧基或低级烷氧羰基,R 4和R 5各自是 氢,1至5个碳原子的烷基,一或二羟基 - (1至5个碳原子的烷基),烯基或2至4个碳原子,5至7个碳原子的环烷基,一或二羟基 - (5至7个碳原子的环烷基)或苄基,或非毒性,药理学上可接受的酸添加盐; 以及使用它们作为抗生素,秘密,抗生素和生物活性物质的抗生素或抗原决定因子的方法。

    Aminobenzyl-amines and salts thereof
    4.
    发明授权
    Aminobenzyl-amines and salts thereof 失效
    氨基苄基胺及其盐

    公开(公告)号:US4101671A

    公开(公告)日:1978-07-18

    申请号:US780903

    申请日:1977-03-24

    摘要: Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is fluorine, alkyl of 1 to 4 carbon atoms, trifluoromethyl, cyano, carbamoyl, carboxyl, carbalkoxy, alkoxy, acetyl, 1-hydroxyethyl or ##STR2## where R.sub.6 and R.sub.7 are each alkyl, cycloalkyl, hydroxy-cycloalkyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino or morpholino, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy (alkyl of 1 to 5 carbon atoms), alkenyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy (cycloalkyl of 5 to 7 carbon atoms), benzyl, morpholinocarbonylmethyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-methyl-piperazino or camphidino,Provided, however, that when R.sub.3 is carboxyl or carbalkoxy, R.sub.4 and R.sub.5 are other than hydrogen, alkyl, mono- or di-hydroxyalkyl, alkenyl, cycloalkyl, mono- or di-hydroxy-cycloalkyl or benzyl; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as anti-ulcerogenics.

    摘要翻译: 其中R 1是氢或脂族或芳族羧酰基,R 2是氢,氯或溴,R 3是氟,1-4个碳原子的烷基,三氟甲基,氰基,氨基甲酰基,羧基,烷氧基,烷氧基, 乙酰基,1-羟乙基或者其中R 6和R 7各自为烷基,环烷基,羟基 - 环烷基,或彼此连接的氮原子,与它们相连的氮原子,吡咯烷子基,哌啶子基或吗啉代,R 4和R 5各自为 氢,1至5个碳原子的烷基,一或二羟基(1至5个碳原子的烷基),2至4个碳原子的烯基,5至7个碳原子的环烷基,一或二羟基(环烷基 5至7个碳原子),苄基,吗啉代羰基甲基或彼此连接的氮原子,吡咯烷基,哌啶子基,六亚甲基亚氨基,吗啉代,N-甲基 - 哌嗪子基或樟脑酸,提供,但是当R3 是羧基或烷氧基,R4和R5不同于氢 烷基,单 - 或二 - 羟基烷基,烯基,环烷基,单 - 或二 - 羟基 - 环烷基或苄基; 和无毒的,药学上可接受的酸加成盐。 化合物及其盐可用作抗溃疡发生剂。

    Aminobenzyl-amines and salts thereof
    5.
    再颁专利
    Aminobenzyl-amines and salts thereof 失效
    氨基苄基胺及其盐

    公开(公告)号:USRE29628E

    公开(公告)日:1978-05-09

    申请号:US746954

    申请日:1976-12-02

    摘要: Compounds of the formula ##STR1## wherein R.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is fluorine, alkyl of 1 to 4 carbon atoms, trifluoromethyl, cyano, carbamoyl, carboxyl, carbalkoxy, alkoxy, acetyl, 1-hydroxyethyl or ##STR2## where R.sub.6 and R.sub.7 are each alkyl, cycloalkyl, hydroxy-cycloalkyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino or morpholino, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy (alkyl of 1 to 5 carbon atoms), alkenyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy(cycloalkyl of 5 to 7 carbon atoms), benzyl, morpholinocarbonylmethyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-methyl-piperazino or camphidino, and non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anti-ulcerogenics, secretolytics, .[.antitussive,.]. .Iadd.antitussives .Iaddend.and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.

    Aminobenzyl-amides and salts thereof
    6.
    发明授权
    Aminobenzyl-amides and salts thereof 失效
    氨基苄基酰胺及其盐

    公开(公告)号:US3950393A

    公开(公告)日:1976-04-13

    申请号:US458099

    申请日:1974-04-05

    摘要: Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen or aliphatic or aromatic carboxylic acyl,R.sub.2 is hydrogen, chlorine or bromine,R.sub.3 is fluorine, alkyl of 1 to 4 carbon atoms, trifluoromethyl, cyano, carbamoyl, carboxyl, carbalkoxy, alkoxy, acetyl, 1-hydroxyethyl or ##EQU1## where R.sub.6 and R.sub.7 are each alkyl, cycloalkyl, hydroxy-cycloalkyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino or morpholino, andR.sub.4 and R.sub.5 are each hydrogen, alkyl of 1 to 5 carbon atoms, mono- or di-hydroxy (alkyl of 1 to 5 carbon atoms), alkenyl of 2 to 4 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, mono- or di-hydroxy(cycloalkyl of 5 to 7 carbon atoms), benzyl, morpholinocarbonylmethyl or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-methyl-piperazino or camphidino,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anti-ulcergenics, secretolytics, antitussive, and stimulants of the production of the surfactant or antiatelectasis factor of the alveoli.

    摘要翻译: 式WHEREIN R 1的化合物是氢或脂族或芳族羧酸酰基,R 2是氢,氯或溴,R 3是氟,1至4个碳原子的烷基,三氟甲基,氰基,氨基甲酰基,羧基,烷氧基,烷氧基,乙酰基, 羟乙基或R6 -CH2-N ANGLE R7,其中R6和R7各自为烷基,环烷基,羟基 - 环烷基或彼此连接的氮原子,吡咯烷基,哌啶子基或吗啉代,R4和R5各自为 氢,1至5个碳原子的烷基,一或二羟基(1至5个碳原子的烷基),2至4个碳原子的烯基,5至7个碳原子的环烷基,一或二羟基(环烷基 5至7个碳原子),苄基,吗啉代羰基甲基或彼此连接的氮原子,吡咯烷基,哌啶子基,六亚甲基亚氨基,吗啉代,N-甲基哌嗪基或卡宾多,以及非毒性,药理学上可接受的 其添加量: 化合物作为其生物利用作为抗生素,秘密,抗生素和生物活性成分或抗生素因子的有效途径。

    Amino-benzoic acid amides
    7.
    发明授权
    Amino-benzoic acid amides 失效
    氨基 - 苯甲酸酰胺

    公开(公告)号:US4093734A

    公开(公告)日:1978-06-06

    申请号:US734818

    申请日:1976-10-22

    摘要: Compounds of the formula ##STR1## wherein (A) WHEN THE AMINO-SUBSTITUENT IS IN THE P-POSITION WITH RESPECT TO THE CARBONYL GROUP,R.sub.1 is chlorine in the o-position with respect to the carbonyl group,R.sub.2 is hydrogen, andR.sub.3 is ethylamino, cyclopentylamino, cyclohexylamino, cycloheptylamino, N-methyl-cyclohexylamino, benzylamino or 1-ethyl-pyrrolidyl-(2)-aminomethyl, or(b) when the amino-substituent is in the o--, m-- or p-position with respect to the carbonyl group,R.sub.1 is hydrogen, chlorine or bromine,R.sub.2 is trifluoromethyl, nitro or, when R.sub.4 is 1-(alkyl of 1 to 3 carbon atoms)-pyrrolidyl or 1-(alkyl of 1 to 3 carbon atoms)-piperidyl, also fluorine, chlorine, bromine or methyl,R.sub.3 is (alkyl of 1 to 5 carbon atoms)-amino, (cycloalkyl of 3 to 7 carbon atoms)-amino, benzylamino, quinuclidinyl-amino or --NH--(CH.sub.2).sub.n --R.sub.4where R.sub.4 is pyridyl, 1-(alkyl of 1 to 3 carbon atoms)-pyrrolidyl, 1-(alkyl of 1 to 3 carbon atoms)-piperidyl or, when n is 2 or 3, also imidazolonyl, pyrrolidino, piperidino or morpholino, andn is 0, 1, 2 or 3,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as anxiolytics, anticonvulsives, antiemetics and antiulcerogenics.

    摘要翻译: 式(A)的化合物其中(A)当氨基取代基位于与碳组相对位置时,R 1为相对于羰基的o位置的氯,R 2为氢,R 3为 是乙基氨基,环戊基氨基,环己基氨基,环庚基氨基,N-甲基 - 环己基氨基,苄基氨基或1-乙基 - 吡咯烷基 - (2) - 氨基甲基,或(B)当氨基取代基位于O-, 对于羰基,R1是氢,氯或溴,R2是三氟甲基,硝基,或当R4是1-(1至3个碳原子的烷基) - 吡咯烷基或1-(1至3个碳原子的烷基)时, - 哌啶基,氟,氯,溴或甲基,R3是(碳原子数1〜5的烷基) - 氨基,(3〜7个碳原子的环烷基) - 氨基,苄基氨基,奎宁环基 - 氨基或-NH-(CH2) n-R4,其中R4是吡啶基,1-(1至3个碳原子的烷基) - 吡咯烷基,1-(1至3个碳原子的烷基) - 哌啶基,或当n是2或3时,也是咪唑啉基,吡咯烷子基,哌啶子基 或mor pholino和N IS 0,1,2或3,以及非毒性,药理学上可接受的酸添加量; 化合物作为它们的有效的有用的ANXIOLYTICS,ANTICONVULSIVES,抗原和抗生素。

    Pharmaceutical compositions containing a
3-(amino-methylene)-5-phenyl-1,4-benzodiazepin-2-one and method of use
    8.
    发明授权
    Pharmaceutical compositions containing a 3-(amino-methylene)-5-phenyl-1,4-benzodiazepin-2-one and method of use 失效
    含有3-(氨基 - 亚甲基)-5-苯基-1,4-苯并二氮杂-2-酮的药物组合物及其使用方法

    公开(公告)号:US3956492A

    公开(公告)日:1976-05-11

    申请号:US532069

    申请日:1974-12-12

    摘要: Pharmaceutical dosage unit compositions containing as an active ingredient a compound of the formula ##SPC1##WhereinR.sub.1 and R.sub.2, which may be identical to or different from each other, are each hydrogen, cycloalkyl, phenyl, --A--YwhereinA is alkyl of 1 to 5 carbon atoms or alkenyl of 1 to 5 carbon atoms, andY is furyl, dialkylamino, hydroxyl, carbalkoxy or carbamido,Or, together with each other and the nitrogen atom to which they are attached, pyrrolidino, piperidino, hexamethyleneimino, morpholino, thiomorpholino, thiomorpholino-S-oxide or N'-alkylpiperazino,R.sub.3 is halogen, nitro or trifluoromethyl,R.sub.4 is hydrogen, halogen or trifluoromethyl, andR.sub.5 is hydrogen, alkyl, cycloalkyl-methyl, alkylamino-alkyl, dialkylamino-alkyl or trifluoromethyl-alkyl;And a method of using the same as sedatives, tranquilizers, muscle-relaxants and anticonvulsives.

    摘要翻译: 含有作为活性成分的式WHEREIN R1和R2彼此相同或不同的化合物的药物剂量单位组合物各自为氢,环烷基,苯基,其中A为1至5个碳原子的烷基 或1至5个碳原子的链烯基,Y是呋喃基,二烷基氨基,羟基,烷氧羰基或氨基甲酰基,或者与其它任何其它的氮原子一起形成吡啶并吡咯烷酮,哌啶,异丙基苯胺,吗啉,噻唑啉, N-氧化物或N-烷基哌嗪基,R3是卤素,硝基或三氟甲基,R4是氢,卤素或三氟甲基,R5是氢,烷基,环烷基 - 甲基,烷基氨基 - 烷基,二烷基氨基 - 烷基或三氟甲基 - 烷基; 以及将其用作SEDATIVES,TRANQUILIZERS,MUSCLE-RELAXANTS和ANTICONVULSIVES的方法。

    Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
    9.
    发明授权
    Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts 失效
    支气管解痉剂1-(对氨基 - 苯基)-2-氨基 - 乙醇 - (1)和盐

    公开(公告)号:US4119710A

    公开(公告)日:1978-10-10

    申请号:US754981

    申请日:1976-12-28

    CPC分类号: C07D263/04 C07D317/58

    摘要: Racemic and optically active compounds of the formula ##STR1## wherein R.sub.1 is hydrogen, fluorine, chlorine, bromine, iodine or cyano,R.sub.2 is fluorine, trifluoromethyl, nitro or cyano, andR.sub.3 is alkyl of 3 to 5 carbon atoms, hydroxy(alkyl of 3 to 5 carbon atoms), cycloalkyl of 3 to 5 carbon atoms, 1-(3,4-methylenedioxy-phenyl)-2-propyl or 1-(p-hydroxy-phenyl)-2-propyl,And non-toxic, pharmacologically acceptable acid addition salts thereof; the compounds as well as their salts are useful as analgesics, uterospasmolytics, bronchospasmolytics and antispastics for the skeletal musculature, and especially as .beta..sub.2 -receptor mimetics and .beta..sub.1 -receptor blockers.

    摘要翻译: 其中R 1为氢,氟,氯,溴,碘或氰基的外消旋和旋光活性化合物,R 2为氟,三氟甲基,硝基或氰基,R 3为3至5个碳原子的烷基,羟基(烷基 3至5个碳原子的环烷基,3至5个碳原子的环烷基,1-(3,4-亚甲二氧基 - 苯基)-2-丙基或1-(对羟基 - 苯基)-2-丙基,和非毒性 其药理学可接受的酸添加剂; 这些化合物作为其作为骨质疏松症,骨质疏松症,骨质疏松症和骨质疏松症的抗生素有用的化合物,特别适用于β2受体的MIME和β受体阻断剂。

    Benzazepine derivatives, their pharmaceutical compositions and method of
use
    10.
    发明授权
    Benzazepine derivatives, their pharmaceutical compositions and method of use 失效
    苯扎西平衍生物,其药物组合物和使用方法

    公开(公告)号:US4490369A

    公开(公告)日:1984-12-25

    申请号:US547940

    申请日:1983-11-02

    摘要: Compounds of the formula ##STR1## wherein A is --CH.sub.2 --CH.sub.2 --, --CH.dbd.CH--, --NH--CO--, --CH.sub.2 --CO-- or ##STR2## where R.sub.7 is alkyl of 1 to 3 carbon atoms, andB is methylene, carbonyl or thiocarbonyl, orA is --CO--CO--, --N.dbd.CH--, ##STR3## where R.sub.8 is hydrogen or alkyl of 1 to 3 carbon atoms substituted by a phenyl, methoxyphenyl or dimethoxyphenyl, andB is methylene;E is n-alkylene of 2 to 4 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, 2-hydroxy-n-propylene, 2-hydroxy-n-butylene or 3-hydroxy-n-butylene;G is n-alkylene of 1 to 5 carbon atoms optionally substituted by an alkyl of 1 to 3 carbon atoms, wherein one methylene group of an n-alkylene of 2 to 5 carbon atoms can be replaced by a carbonyl group, with the proviso that B represents a methylene or carbonyl group, or methylene-n-hydroxy-alkylene of 1 to 4 carbon atoms, where the methylene group is attached to the nitrogen atom; andR.sub.1 to R.sub.5 are simple substituents of various types;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as bradycardiacs.

    摘要翻译: 其中A是-CH 2 -CH 2 - , - CH = CH - , - NH-CO-, - CH 2 -CO-或者其中R 7是1至3个碳原子的烷基,和B 是亚甲基,羰基或硫代羰基,或A是-CO-CO-,-N = CH-,其中R 8是氢或被苯基,甲氧基苯基或二甲氧基苯基取代的1至3个碳原子的烷基,和 B是亚甲基; E是任选被1至3个碳原子的烷基取代的2至4个碳原子的正亚烷基,2-羟基 - 正丙烯,2-羟基 - 正丁烯或3-羟基 - 正丁烯; G是任选被1至3个碳原子的烷基取代的1至5个碳原子的正亚烷基,其中2至5个碳原子的正亚烷基的一个亚甲基可被羰基取代,条件是 B表示亚甲基或羰基,或亚甲基与氮原子连接的1至4个碳原子的亚甲基 - 正 - 羟基 - 亚烷基; 而R1至R5是各种简单的取代基; 和无毒的,药学上可接受的酸加成盐。 化合物及其盐可用作心动过缓。